Colesevelam in the management of type 2 diabetes.

Kalra, Sanjay; Priya, Gagan; Aggarwal, Sameer

Kalra, Sanjay; Priya, Gagan; Aggarwal, Sameer.

Afiliação

Kalra S; Department of Endocrinology, Bharti Hospital, Karnal, India.
Priya G; Department of Endocrinology, Fortis Hospital, Mohali, India.
Aggarwal S; Department of Endocrinology, Apex Hospital, Rohtak, India.

J Pak Med Assoc ; 70(5): 934-936, 2020 May.

Article em En | MEDLINE | ID: mdl-32400758

ABSTRACT

ABSTRACT

Colesevelam is a bile acid sequestrant, approved for the management of both dyslipidaemia and type 2 diabetes. This review discusses the potential for the use of colesevelam in the management of type 2 diabetes. Expert opinion suggests possible indications where colesevelam may add value as a glucose lowering agent. It also highlights the limitations of the drug, and precautions that must be observed while using it.

Assuntos

Cloridrato de Colesevelam/farmacologia; Diabetes Mellitus Tipo 2; Dislipidemias/tratamento farmacológico; Anticolesterolemiantes/farmacologia; Diabetes Mellitus Tipo 2/tratamento farmacológico; Diabetes Mellitus Tipo 2/metabolismo; Dislipidemias/metabolismo; Humanos; Farmacovigilância

Palavras-chave

bile acid sequestrant, colesevelam, GLP1RA, LDL cholesterol, lipocrinology, type 2 diabetes

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Dislipidemias / Cloridrato de Colesevelam Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links